−18.55 MCHF
65.90 M
About SPEXIS AG
Sector
CEO
Jeffrey D. Wager
Headquarters
Allschwil
Website
Employees (FY)
28
Founded
1996
ISIN
CH0106213793
FIGI
BBG00KK1Z4Q5
Spexis Ltd. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of respiratory therapeutics. The firm focuses on rare, chronic respiratory diseases (CRD) and chronic lung infections in cystic fibrosis. Its product pipeline includes ColiFin, Inhaled Murepavadin, Balixafortide (POL6326), OMPTA, EBX-002, and POL6014 (Lonodelestat). The company was founded by Daniel Obrecht and Jean-Pierre Obrecht in 1996 and is headquartered in Allschwil, Switzerland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 29Y is 0.120 CHF — it has decreased by 24.05% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange SPEXIS AG stocks are traded under the ticker 29Y.
SPEXIS AG is going to release the next earnings report on Sep 5, 2024. Keep track of upcoming events with our Earnings Calendar.
29Y stock is 31.67% volatile and has beta coefficient of −1.90. Check out the list of the most volatile stocks — is SPEXIS AG there?
SPEXIS AG revenue for the last quarter amounts to 0 CHF despite the estimated figure of 0 CHF. In the next quarter revenue is expected to reach 600.00 K CHF.
Yes, you can track SPEXIS AG financials in yearly and quarterly reports right on TradingView.
Today SPEXIS AG has the market capitalization of 4.05 M, it has decreased by 18.88% over the last week.
No, 29Y doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 29Y shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SPEXIS AG stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 28.00 employees. See our rating of the largest employees — is SPEXIS AG on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SPEXIS AG technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SPEXIS AG stock shows the sell signal. See more of SPEXIS AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.